SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19481350
Source:
http://linkedlifedata.com/resource/pubmed/id/19481350
Search
Subject
(
53
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0000854
,
umls-concept:C0002679
,
umls-concept:C0006434
,
umls-concept:C0024453
,
umls-concept:C0037633
,
umls-concept:C0043250
,
umls-concept:C0205373
,
umls-concept:C0332237
,
umls-concept:C1382100
,
umls-concept:C1522168
,
umls-concept:C2347946
pubmed:issue
1
pubmed:dateCreated
2010-2-1
pubmed:abstractText
To determine if patients receiving topical amphotericin B in combination with 5% mafenide acetate solution will acquire systemically detectable levels of amphotericin B.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8913178
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Amphotericin B
,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Infective Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Infective Agents, Local
,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations
,
http://linkedlifedata.com/resource/pubmed/chemical/Mafenide
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1879-1409
pubmed:author
pubmed-author:HolmesJames HJH4th
,
pubmed-author:PendletonRachel ARA
pubmed:copyrightInfo
Copyright (c) 2009 Elsevier Ltd and ISBI. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
38-41
pubmed:meshHeading
pubmed-meshheading:19481350-Administration, Cutaneous
,
pubmed-meshheading:19481350-Amphotericin B
,
pubmed-meshheading:19481350-Anti-Infective Agents
,
pubmed-meshheading:19481350-Anti-Infective Agents, Local
,
pubmed-meshheading:19481350-Burns
,
pubmed-meshheading:19481350-Drug Administration Schedule
,
pubmed-meshheading:19481350-Drug Combinations
,
pubmed-meshheading:19481350-Graft Survival
,
pubmed-meshheading:19481350-Humans
,
pubmed-meshheading:19481350-Mafenide
,
pubmed-meshheading:19481350-Postoperative Care
,
pubmed-meshheading:19481350-Prospective Studies
,
pubmed-meshheading:19481350-Skin Absorption
,
pubmed-meshheading:19481350-Surgical Wound Infection
pubmed:year
2010
pubmed:articleTitle
Systemic absorption of amphotericin B with topical 5% mafenide acetate/amphotericin B solution for grafted burn wounds: is it clinically relevant?
pubmed:affiliation
North Carolina Baptist Hospital, and Wake Forest University School of Medicine, Winston-Salem, NC 27157, United States.
pubmed:publicationType
Journal Article
,
Clinical Trial